Other Insiders Active in the Same Sector
No other insider has filed at Dominick Colangelo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Steven Leonard Chapman - $93.37M of NTRA open-market activity in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M of KROS open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $83.13M of VOR open-market activity in the last 12 months
- Matthew Rabinowitz - $82.72M of NTRA open-market activity in the last 12 months
- Mark T. Bertolini - $82.60M of OSCR open-market activity in the last 12 months
- Frank Torti - $82.04M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dominick Colangelo?
Dominick Colangelo is a corporate insider of Trevi Therapeutics, Inc. (TRVI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dominick Colangelo submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Dominick Colangelo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($3.35M) across all tracked filings.
Where can I see all of Dominick Colangelo's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dominick Colangelo and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
